ReLumeTM is the first technological
breakthrough to offer a practical treatment solution for leukoderma,
or skin conditions in which pigment loss has occurred. ReLume
combines the benefits of safe and effective UV phototherapy
with the latest advances in targeted light technology to achieve
selective repigmentation of hypopigmented skin.
ReLume improves the appearance of several hypopigmented
skin conditions, including acne scars, traumatic and surgical
scars, laser-resurfaced and chemically-peeled skin, and mature
stretch marks. This no downtime procedure is painless and safe
for all skin types.
Loss of skin pigmentation occurs as a complication
of injury to the skin from trauma, surgery, laser therapy and
burns. Pigment loss is also noted in mature stretch marks that
occur as a result of pregnancy or from rapid weight gain. An
estimated 90% of pregnant women, 70% of adolescent females and
40% of adolescent males develop stretch marks.1 ReLume
offers an effective treatment solution for patients who have
lost pigment anywhere on the body.
1 Arnold HL, James WD, Odom
RB. Abnormalities of dermal connective tissue. In: Odom RB,
James WD, Berger TG, ed. Andrews' diseases of the skin: clinical
dermatology. 9th edn. Philadelphia: W.B. Saunders Co., 2000:
ReLume precisely delivers therapeutic 290 to 320
nanometer light. These wavelengths stimulate the migration and
proliferation of melanocytes and the production and maturation
of melanin pigment. With ReLume, restoration of lost pigment
is routinely achieved within just weeks. Patients return to
their normal activities immediately and, as pigment is restored,
the appearance of mature stretch marks and hypopigmented scars
is significantly improved.
fiber-optic, localized delivery of light
optics adjust size and shape of treatment spot
accuracy is optimized with handpiece distance gauge and aiming
treatments can be administered by staff
system and portable cart for convenient transport
reliability and service with guaranteed overnight replacement
of system or components2
2 Based on service availability
from FedEx. Not available in all countries.
The ReLume™ Repigmentation Phototherapy System has received
FDA marketing clearance for the treatment of leukoderma, or
the loss of skin pigmentation. For stretch marks, acne scars,
post-surgical and traumatic scars, burns, grafted skin and laser-resurfaced
or chemically-peeled skin, lost pigment can now be restored
safely and effectively, often within just weeks.
Stretch marks and acne scars are two of the most
common examples of hypopigmented skin, which affect men and
women of all ages, including adolescents. According to the American
Academy of Dermatology, 90 percent of pregnant women develop
stretch marks during the 6th and 7th months of pregnancy, and
80 percent of the population from 11 to30 years-of-age suffer
from acne, with millions bearing the scars of this skin condition.
ReLume’s unique light-based therapy improves the appearance
of stretch marks and acne scars by restoring pigment to skin
that is affected by such conditions.
Topical retinoids and laser treatments can improve
the clinical appearance of early stretch marks and scars, but,
until now, there have been few effective therapies for patients
with mature stretch marks and hypopigmented scars. Frustrated
with the lack of treatment options for hypopigmented skin conditions,
patients are looking for a viable solution. The new ReLume system
is now available and offers an effective treatment solution
for these skin conditions.
Learn more about how light can be used to treat
stretch marks and other hypopigmented scars. Click
here to view an article in PDF format.